← FDA Drug Approvals (Drugs@FDA)

BYDUREON PEN

NDA · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2012-01-27

Drug application

FDA Application #

NDA022200

Application type

New Drug Application

Brand name

BYDUREON PEN

Generic name

Exenatide Synthetic

Active ingredients

EXENATIDE SYNTHETIC

Dosage form

FOR SUSPENSION, EXTENDED RELEASE

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

ASTRAZENECA AB

First approval

2012-01-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown